Pathstone Family Office, LLC Abbott Laboratories Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Pathstone Family Office, LLC holds 143,541 shares of ABT stock, worth $16.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

143,541

Previous 44,397 223.31%

Holding current value

$16.5 Million

Previous $4.84 Million 187.21%

% of portfolio

0.09%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $9.47 Million - $11.4 Million	99,144 Added 223.31%	143,541 $13.9 Million
Q2 2023 Jan 12, 2024	SELL	$100.78 - $112.29 $9.91 Million - $11 Million	-98,325 Reduced 68.5%	45,216 $4.93 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $602,462 - $671,269	5,978 Added 15.56%	44,397 $4.84 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $3.49 Million - $4.1 Million	-35,982 Reduced 48.36%	38,419 $3.89 Million
Q4 2022 Oct 23, 2023	BUY	$95.06 - $111.52 $3.37 Million - $3.95 Million	35,448 Added 91.0%	74,401 $8.17 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $365,410 - $428,682	3,844 Added 5.45%	74,401 $8.17 Million
Q3 2022 Oct 23, 2023	BUY	$96.76 - $112.03 $1.12 Million - $1.29 Million	11,542 Added 42.11%	38,953 $3.77 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.33 Million - $1.54 Million	13,774 Added 24.26%	70,557 $6.86 Million
Q2 2022 Oct 23, 2023	SELL	$102.07 - $123.37 $1.73 Million - $2.1 Million	-16,986 Reduced 38.26%	27,411 $2.98 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $4.48 Million - $5.41 Million	43,881 Added 340.11%	56,783 $6.17 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $76,393 - $93,156	-670 Reduced 4.94%	12,902 $1.57 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $89,073 - $109,065	-771 Reduced 5.38%	13,572 $1.91 Million
Q3 2021 Nov 16, 2021	BUY	$116.66 - $129.06 $2,099 - $2,323	18 Added 0.13%	14,343 $1.69 Million
Q2 2021 Aug 31, 2021	BUY	$105.79 - $124.53 $639,923 - $753,281	6,049 Added 73.09%	14,325 $1.66 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $489,671 - $576,906	4,499 Added 119.12%	8,276 $992,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $52,185 - $56,866	497 Added 15.15%	3,777 $414,000
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $17,594 - $21,367	-192 Reduced 5.53%	3,280 $357,000
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $14,088 - $18,032	-184 Reduced 5.03%	3,472 $315,000
Q1 2020 Jun 11, 2020	BUY	$62.82 - $91.86 $229,669 - $335,840	3,656 New	3,656 $289,000
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $212,708 - $311,037	-3,386 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $3,925 - $4,370	50 Added 1.5%	3,386 $2.94 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $599,641 - $650,197	-7,327 Reduced 68.71%	3,336 $278,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $117,409 - $136,935	1,611 Added 17.8%	10,663 $897,000
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $565,717 - $683,952	8,543 Added 1678.39%	9,052 $724,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $5,507 - $6,238	84 Added 19.76%	509 $37,000
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $24,006 - $26,496	-417 Reduced 49.52%	425 $26,000
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $23,464 - $26,529	417 Added 98.12%	842 $50,000
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $215,549 - $240,575	-4,485 Reduced 91.34%	425 $23,000
Q2 2017 Aug 16, 2017	BUY	N/A	4,910	4,910 $239,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Abbott Laboratories Transaction History